Brief: Arcadia Biosciences Says On July 2, Co & Stanley Jacot, Jr. Entered Into Separation Agreement Pursuant To Which Jacot Resigned As Co's CEO

Arcadia Biosciences

08/07/2024 21:24

July 8 (Reuters) - Arcadia Biosciences Inc  RKDA.O :
    * ARCADIA BIOSCIENCES -ON JULY 2, CO & STANLEY JACOT, JR.
ENTERED
INTO SEPARATION AND RELEASE AGREEMENT PURSUANT TO WHICH JACOT
RESIGNED AS CO’S CEO
    * ARCADIA BIOSCIENCES -ON JULY 3, APPOINTED THOMAS J.
SCHAEFER TO
POSITION OF PRESIDENT AND CEO OF CO, EFFECTIVE AS OF JULY 5,
2024
    * ARCADIA BIOSCIENCES -ON JULY 3, APPOINTED MARK KAWAKAMI AS
CO'S
NEW CFO TO SUCCEED SCHAEFER, EFFECTIVE AS OF JULY 5, 2024

Source text for Eikon:  ID:n0000950170-24-082092 
Further company coverage:  RKDA.O 

 ((Reuters.Briefs@thomsonreuters.com;))